ALDORIL 15 Drug Patent Profile
✉ Email this page to a colleague
When do Aldoril 15 patents expire, and when can generic versions of Aldoril 15 launch?
Aldoril 15 is a drug marketed by Merck and is included in one NDA.
The generic ingredient in ALDORIL 15 is hydrochlorothiazide; methyldopa. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; methyldopa profile page.
Summary for ALDORIL 15
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Patent Applications: | 26 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ALDORIL 15 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ALDORIL 15
US Patents and Regulatory Information for ALDORIL 15
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | ALDORIL 15 | hydrochlorothiazide; methyldopa | TABLET;ORAL | 013402-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |